University of Minnesota
Minneapolis, Minnesota, 55455, United States
NCT Number: NCT02747680
This research study is designed to investigate the effect of hypoglycemia (low blood sugar) on blood flow to and biochemistry in the brain.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Minneapolis, Minnesota, 55455, United States
The purpose of this study is to better understand the effect of low blood sugar (hypoglycemia) on blood flow and biochemistry in the brain. Hypoglycemia is a serious complication of diabetes treatments. It has been previously observed that hypoglycemia causes an increase in blood flow to certain parts of the brain, but it has been difficult to determine which parts of the brain specifically have an increase in blood flow. With new technology, it is now possible to determine the rate of blood flow in very small parts of the brain. The investigator expects that people with type 1 diabetes and hypoglycemia unawareness, poorly controlled diabetes, and normal subjects will have different rates of blood flow to different parts of the brain in response to hypoglycemia. Having a greater understanding of how the brain adapts to hypoglycemia may help us develop better ways to treat diabetes more safely.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
hypoglycemia (low blood sugar) in MRI
Time frame: baseline
Brain activation during euglycemia (normal blood sugar) using functional MRI
Time frame: baseline
Brain activation during hypoglycemia (low blood sugar) using functional MRI
University of Minnesota
Other
Acronym: 1018
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01474889
Autoimmune Diseases, Consciousness Disorders
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT04614168
Autoimmune Diseases, Diabetes Mellitus
Edinburgh, United Kingdom
View Trial DetailsNCT04825366
Autoimmune Diseases, Diabetes Mellitus
Montreal, Quebec, Canada
View Trial DetailsNCT02829593
Autoimmune Diseases, Diabetes Mellitus
Minneapolis, Minnesota, United States
View Trial Details